Skip to main content
    G

    Geron Corporation (GERN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.94
    -0.03 (-2.60%)

    Market Cap: $622.98M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Geron Corporation (GERN) Financials: Revenue, Profit and Cash Flow

    Updated Nov 4, 2026. Financial statements from company filings, amounts in US dollars.

    Geron reported revenue of $183.88M for the fiscal year ended Dec 31, 2025, up 138.8% from the year before. That year, net income was -$83.50M with a net margin of -45.4%, operating cash flow was -$111.04M and free cash flow was -$111.09M. The quarter ended Sep 30, 2026 had revenue of $60.19M and net income of $1.35M.

    Revenue and Margins

    The operating margin was -37.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $6.16M, a compound annual rate of 45.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$183.88M+138.8%97.4%-37.3%-45.4%
    Dec 2024$76.99MN/A98.4%-225.6%-226.7%
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0-100.0%N/AN/AN/A
    Dec 2021$1.39M+450.6%100.0%-8183.7%-8335.4%
    Dec 2020$253.00K-45.0%100.0%-30400.4%-29888.1%
    Dec 2019$460.00K-56.8%100.0%-15762.0%-14901.7%
    Dec 2018$1.07M+0.1%100.0%-2914.9%-2534.4%
    Dec 2017$1.06M-82.7%100.0%-2746.9%-2621.2%
    Dec 2016$6.16MN/A100.0%-497.3%-479.3%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$183.88M$76.99M$0$0$1.39M$253.00K$460.00K$1.07M$1.06M$6.16M
    Cost of revenue$4.75M$1.26M$0$0$0$0$0$0$0$0
    Gross profit$179.14M$75.74M$0$0$1.39M$253.00K$460.00K$1.07M$1.06M$6.16M
    Research and development$71.43M$103.74M$125.05M$95.52M$85.73M$51.49M$52.07M$13.43M$11.03M$18.05M
    Operating income-$68.58M-$173.73M-$193.94M-$138.55M-$114.00M-$76.91M-$72.50M-$31.07M-$29.25M-$30.65M
    Net income-$83.50M-$174.57M-$184.13M-$141.90M-$116.11M-$75.62M-$68.55M-$27.02M-$27.92M-$29.54M
    EBITDAN/AN/AN/A-$136.32M-$109.80M-$74.75MN/AN/A-$28.98M-$30.10M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$60.19M$57.48M$51.84M$48.02M$47.23M$49.04M$39.60M$47.54M$28.27M$882.00K$304.00K-$193.00K
    Gross profit$54.14M$48.24M$50.15M$46.71M$46.18M$47.85M$38.40M$46.75M$27.82M$865.00K$304.00K-$193.00K
    Operating income$5.80M-$12.50M$158.00K-$25.54M-$13.89M-$12.45M-$16.70M-$20.05M-$28.21M-$69.33M-$56.13M-$54.29M
    Net income$1.35M-$16.68M-$3.64M-$28.86M-$18.43M-$16.38M-$19.84M-$25.35M-$26.45M-$67.38M-$55.39M-$51.97M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $139.00M exceeded cash and equivalents by $61.44M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$570.54M$593.78M$394.08M$190.57M$226.03M$270.73M$165.52M$185.28M$110.31M$130.25M
    Current assets$520.27M$490.99M$341.35M$180.25M$187.21M$199.86M$141.61M$166.06M$95.97M$116.11M
    Cash and equivalents$77.56M$79.02M$70.02M$56.84M$34.87M$9.93M$13.64M$10.57M$16.34M$12.81M
    Total liabilities$344.67M$313.46M$146.13M$110.58M$99.62M$59.78M$30.36M$7.55M$6.52M$7.87M
    Short-term debt$19.45M$974.00K$46.89M$20.95M$0$878.00K$354.00KN/AN/AN/A
    Long-term debt$119.55M$118.48M$35.05M$30.21M$49.83M$24.04M$0N/A$0$0
    Shareholder equity$225.87M$280.32M$247.95M$80.00M$126.42M$210.95M$135.16M$177.73M$103.80M$122.38M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$527.11M$519.01M$534.12M$570.54M$567.38M$555.20M$562.45M$593.78M$444.95M$449.40M$482.07M$394.08M
    Total liabilities$300.41M$300.39M$305.01M$344.67M$318.68M$295.67M$294.21M$313.46M$152.67M$142.70M$137.21M$146.13M
    Cash and equivalents$69.18M$62.64M$68.89M$79.44M$78.12M$77.73M$83.75M$79.02M$60.34M$116.94M$189.76M$71.14M
    Shareholder equity$226.69M$218.61M$229.11M$225.87M$248.71M$259.53M$268.24M$280.32M$292.28M$306.69M$344.87M$247.95M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$111.04M-$218.62M-$167.74M-$127.38M-$95.56M-$66.65M-$43.83M-$21.01M-$20.56M-$18.37M
    Capital expenditures$49.00K$680.00K$830.00K$431.00K$207.00K$401.00K$413.00K$16.00K$16.00K$57.00K
    Free cash flow-$111.09M-$219.30M-$168.57M-$127.81M-$95.76M-$67.05M-$44.24M-$21.02M-$20.57M-$18.43M
    Investing cash flow$107.25M-$106.00M-$180.32M$62.07M$71.95M-$105.32M$27.40M-$77.72M$22.97M$8.76M
    Financing cash flow$2.27M$334.37M$362.02M$87.26M$48.56M$168.35M$19.50M$92.97M$1.11M$1.17M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$10.27M-$15.83M-$62.91M-$22.07M-$13.58M-$27.41M-$47.98M-$43.95M-$58.94M-$53.48M-$62.25M-$40.94M
    Capital expenditures$154.00K$223.00K$252.00K$32.00K$89.00K$170.00K$32.00K$141.00K$0$206.00K$615.00K$64.00K
    Free cash flow$10.11M-$16.05M-$63.16M-$22.10M-$13.66M-$27.59M-$48.01M-$44.09M-$58.94M-$53.68M-$62.87M-$41.00M
    Last 12 quarters

    Frequently Asked Questions About GERN

    What is Geron's annual revenue?

    Geron reported revenue of $183.88M for the fiscal year ended Dec 31, 2025.

    How fast is Geron's revenue growing?

    Revenue was up 138.8% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is Geron profitable?

    No. Geron reported net income of -$83.50M for the fiscal year ended Dec 31, 2025, with a net margin of -45.4%.

    How much free cash flow does GERN generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$111.04M minus capital expenditures of $49.00K produced free cash flow of -$111.09M.

    How much debt does Geron have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $119.55M, short-term debt of $19.45M and cash and equivalents of $77.56M.